{"organizations": [], "uuid": "41936ff2107968342220b9481a597cbb4f7672e9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-chemocentryx-secures-up-to-100-mil/brief-chemocentryx-secures-up-to-100-million-in-new-capital-commitments-idUSFWN1OZ0MG", "country": "US", "domain_rank": 408, "title": "BRIEF-Chemocentryx Secures Up To $100 Million In New Capital Commitments", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-04T14:24:00.000+02:00", "replies_count": 0, "uuid": "41936ff2107968342220b9481a597cbb4f7672e9"}, "author": "", "url": "https://www.reuters.com/article/brief-chemocentryx-secures-up-to-100-mil/brief-chemocentryx-secures-up-to-100-million-in-new-capital-commitments-idUSFWN1OZ0MG", "ord_in_thread": 0, "title": "BRIEF-Chemocentryx Secures Up To $100 Million In New Capital Commitments", "locations": [], "entities": {"persons": [], "locations": [{"name": "new capit", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "eu", "sentiment": "none"}, {"name": "chemocentryx inc", "sentiment": "none"}, {"name": "chemocentryx", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "chemocentryx inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 4, 2018 / 12:24 PM / in 9 minutes BRIEF-Chemocentryx Secures Up To $100 Million In New Capital Commitments Reuters Staff \nJan 4 (Reuters) - Chemocentryx Inc: \n* CHEMOCENTRYX SECURES UP TO $100 MILLION IN NEW CAPITAL COMMITMENTS \n* CHEMOCENTRYX INC SAYS WILL RECEIVE $50 MILLION MILESTONE PAYMENT FROM VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA \n* CHEMOCENTRYX INC - CO ALSO ENTERS INTO $50 MILLION GROWTH CAPITAL FINANCING AGREEMENT WITH HERCULES CAPITAL \n* CHEMOCENTRYX INC SAYS ALSO ENTERS INTO $50 MILLION GROWTH CAPITAL FINANCING AGREEMENT WITH HERCULES CAPITAL \n* CHEMOCENTRYX - ‍ADDITIONAL CAPITAL TO PROVIDE FUNDING TO ADVANCE AVACOPAN THROUGH TOPLINE DATA FROM PHASE III ADVOCATE TRIAL \n* CHEMOCENTRYX INC - ADDITIONAL CAPITAL ALSO EXPECTED TO PROVIDE FUNDING​ FOR‍ POTENTIAL REGISTRATION FILINGS IN U.S. AND EU. Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-04T14:24:00.000+02:00", "crawled": "2018-01-04T14:36:05.004+02:00", "highlightTitle": ""}